Liotta, Petricoin Using Protein Array Technology to Test Gleevec for Colorectal Cancer
January 22, 2010
Liotta, Petricoin Using Protein Array Technology to Test Gleevec for Colorectal Cancer
The GMU researchers and their collaborators are in the midst of a clinical trial that they said is one of the first applications of proteomics technology for personalized medicine.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- UCLA Study Identifies Leukemia Pathways Potentially Involved in Gleevec Resistance
March 25, 2011 / ProteoMonitor - GMU's Petricoin Building Database That Details Activation in Cancer Protein Pathways
August 13, 2010 / ProteoMonitor - GMU Developing Proteomic Profile to Personalize Gleevec Treatment for CRC; Novartis Provides Funding
January 20, 2010 / Pharmacogenomics Reporter - Evotec to Use PhosphoScout Platform in Oncology Biomarker Alliance with Roche
July 1, 2011 / ProteoMonitor - Duke Team Identifies Phosphoprotein Signatures That Could Predict Breast Cancer Risk
November 12, 2010 / ProteoMonitor